Envirotainer, the specialist in secure cold chain solutions for the shipment of pharmaceuticals, has announced that American Airlines has become the latest global airline to approve the Envirotainer Releye® RLP and RAP containers for usage on its fleet of aircraft.

This approval enables American Airlines to meet the increasing demand to deliver life-saving medicines that need to be temperature-controlled in transit. The airline will be able to better support sensitive shipments in a highly regulated market while providing pharma shippers with secure and sustainable cold chain solutions.

Envirotainer’s Releye® range helps airlines and shippers to meet the strictest standards in pharmaceutical air freight. These advanced containers were created with a focus on control, monitoring, autonomy, and reliability to minimise the likelihood of valuable product loss that could negatively impact patients’ health outcomes.

“We are thrilled to offer our customers another option for moving temperature-sensitive freight with us. The Releye® RLP and RAP containers are reliably designed for transporting critical Life Sciences and Pharmaceutical shipments, making it a perfect addition to our current cold-chain network,” said Eric Mathieu, Head of Customer Experience for American Airlines Cargo.

“The addition of American Airlines to the growing family of carriers of our Releye® containers is a significant milestone,” said Don Harrison, Interim CSO at Envirotainer. He continued, “American Airlines can now provide its customers with the latest fully connected solution to ensure the safety and quality of air freight pharmaceutical products throughout the supply chain.”